NasdaqGM - Nasdaq Real Time Price USD

ArriVent BioPharma, Inc. (AVBP)

19.24
+0.49
+(2.61%)
At close: May 15 at 4:00:01 PM EDT
19.24
0.00
(0.00%)
After hours: May 15 at 4:02:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
140,406
94,308
74,590
36,906
Operating Income
-140,406
-94,308
-74,590
-36,906
Net Non Operating Interest Income Expense
12,948
13,820
5,257
0
Pretax Income
-127,458
-80,488
-69,333
-36,906
Net Income Common Stockholders
-127,458
-80,488
-69,333
-36,906
Diluted NI Available to Com Stockholders
-127,458
-80,488
-69,333
-36,906
Basic EPS
-3.76
--
-2.17
-1.15
Diluted EPS
-3.76
--
-2.17
-1.15
Basic Average Shares
33,682.41
--
31,956.66
31,956.66
Diluted Average Shares
33,682.41
--
31,956.66
31,956.66
Total Operating Income as Reported
-140,406
-94,308
-74,590
-36,906
Total Expenses
140,406
94,308
74,590
36,906
Net Income from Continuing & Discontinued Operation
-127,458
-80,488
-69,333
-36,906
Normalized Income
-127,458
-80,488
-69,333
-36,906
Interest Income
12,948
13,820
5,257
0
Net Interest Income
12,948
13,820
5,257
0
EBIT
-140,406
-94,308
-74,590
-36,906
EBITDA
-140,406
-94,308
-74,590
-36,906
Net Income from Continuing Operation Net Minority Interest
-127,458
-80,488
-69,333
-36,906
Normalized EBITDA
-140,406
-94,308
-74,590
-36,906
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 1/26/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BCAX Bicara Therapeutics Inc.
14.47
+5.62%
 
SYRE Spyre Therapeutics, Inc.
14.54
-1.76%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
F6T.DU Fate Therapeutics Inc
0.9182
+7.29%
 
378800.KQ Shaperon Inc.
2,785.00
-5.27%
 
1CVAC.MI CureVac N.V.
3.0600
+0.13%
 
CTNM Contineum Therapeutics, Inc.
3.9400
+2.60%
 
BSFAF BSF Enterprise Plc
0.0350
+75.00%
 
688068.SS Beijing Hotgen Biotech Co., Ltd.
103.99
+5.06%
 
P0F.F Egetis Therapeutics AB (publ)
0.2975
-2.94%